Navigation Links
Spherix Announces Termination of Arla License Agreement
Date:6/23/2009

udy if the results are positive.

About Naturlose

Spherix holds patents on the use of Naturlose as a drug to treat diabetes. Naturlose is D-tagatose, which occurs naturally in small amounts in dairy products. It is a highly soluble white crystal or powder, can be produced with a physical bulk similar to ordinary table sugar, and is 92% as sweet. In the U.S., based on over 10 years of animal, human, and other relevant use and safety data, Naturlose was determined to be Generally Recognized As Safe (GRAS) for use in foods as regulated by the Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act. Naturlose has been approved as a "novel food ingredient" in the European Union (EU) without any restriction on usages.

About Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) is a disease that is characterized by elevated blood glucose in the context of insulin resistance and comparative insulin deficiency. While T2DM is often initially managed by increasing exercise in conjunction with dietary modification, medications are usually needed as the disease progresses. There are an estimated 23.6 million people in the U.S. (7.8% of the population) with diabetes, and 17.9 million cases have been diagnosed. Of the diagnosed diabetes cases, 90% are type 2. As T2DM prevalence rates doubled between 1990 and 2005, the CDC characterized the increase as an epidemic. Customarily considered a disease of adults, T2DM is increasingly being diagnosed in children in correlation to increasing juvenile obesity rates.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company, under the name Biospherics Research. The company now leverages its scientific and technical expertise and experience through its two subsidiaries -- Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is currently running a Phase 3 clinical tr
'/>"/>

SOURCE Spherix Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
2. Spherix Regains Full NASDAQ Compliance
3. Spherix to Exhibit at the BIO 2009 International Convention
4. Spherix Recruiting New Independent Director to Regain NASDAQ Compliance
5. Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board
6. Spherix Announces 2008 Financial Results
7. Spherix Reports 3rd Quarter Earnings
8. Spherix Transfers Stock Listing to Nasdaq Capital Market
9. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
10. Spherix Receives NASDAQ Bid Price Deficiency Letter
11. Spherix Reports 1st Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 The Workgroup for Electronic Data ... use of health IT to create efficiencies in healthcare ... (HPID) Workgroup has developed an issue brief titled, ... Payer?” The HPID Workgroup, a part of WEDI’s Strategic ... for Medicare and Medicaid Services (CMS) to identify common ...
(Date:7/28/2014)... -- Research and Markets has announced the ... report to their offering. ... covers the designing and engineering of completely new biological ... of natural biological systems that provide improved and desirable ... extreme genetic engineering because it not only alters existing ...
(Date:7/28/2014)... 2014 Immunomic Therapeutics, Inc. (ITI) has ... develop potential treatments for glioblastoma multiforme (GBM), the most ... their patented vaccine platform, LAMP-vax. , The agreements, ... on the work of John H. Sampson, MD, PhD, ... Robert Tisch Brain Tumor Center at Duke University Medical ...
(Date:7/28/2014)... California (PRWEB) July 28, 2014 The ... 604.40 billion by 2020, according to a new study ... with the rising demand for effective vaccines and drugs ... with unmet medical needs is expected to drive market ... need to enhance agricultural productivity via the use of ...
Breaking Biology Technology:WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2Global Synthetic Biology Market 2014-2018 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4
... Sciences Holdings, Inc. (OTC Bulletin Board: ... development and commercialization of novel drugs in the therapeutic ... that it has submitted a full proposal to the ... BAA-NIAID-DMID-NIHAI2010097 Development Of Therapeutics For Biodefense .  It ...
... imaging system, scientists have tracked a group of near-infrared ... the body and out again, providing a description of ... could be used in developing therapeutic agents to treat ... of the health effects of air pollution. ...
... 2010 Financial Results ... ... --> ... // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
Cached Biology Technology:Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure 2Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure 3Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure 4Scientist chronicle nanoparticles' journey from the lungs into the body 2Scientist chronicle nanoparticles' journey from the lungs into the body 3Oncothyreon Reports Third Quarter 2010 Financial Results 2Oncothyreon Reports Third Quarter 2010 Financial Results 3Oncothyreon Reports Third Quarter 2010 Financial Results 4Oncothyreon Reports Third Quarter 2010 Financial Results 5Oncothyreon Reports Third Quarter 2010 Financial Results 6Oncothyreon Reports Third Quarter 2010 Financial Results 7Oncothyreon Reports Third Quarter 2010 Financial Results 8Oncothyreon Reports Third Quarter 2010 Financial Results 9Oncothyreon Reports Third Quarter 2010 Financial Results 10Oncothyreon Reports Third Quarter 2010 Financial Results 11
(Date:7/28/2014)... identified areas of the Earth that are high priorities ... Europe is particularly vulnerable, as it has the lowest ... of any continent in ,refugia, areas of biological ... remain relatively constant during times of great environmental change. ... in Scandinavia and Scotland. , The biggest refugia ...
(Date:7/28/2014)... 2014) Rice University researchers are using magnetic beads ... that can be used as microscale models for polymer ... polymers, introduced as theory in the 1950s, can be ... should be of interest to materials scientists who study ... by Rice chemical and biomolecular engineer Sibani Lisa Biswal ...
(Date:7/28/2014)... , July 28, 2014 Research and ... "Biometrics Market in Latin America 2014-2018" report to ... Biometrics measure and analyze biological data. These ... irises, eye retinas, voice patterns, and hand measurements from ... more stored templates. The main purpose of a biometrics ...
Breaking Biology News(10 mins):Study finds Europe's habitat and wildlife is vulnerable to climate change 2Seeing is bead-lieving 2Biometrics Market in Latin America 2014-2018 2
... LANSING, Mich. A Michigan State University researcher ... Prize for the design of a low-cost, energy-efficient ... commercial spaces. Norbert Mϋller, assistant professor in ... John Barrie, of the Appropriate Technology Collaborative in ...
... (EPSCoR) has received $20 million in new funding from ... Regents for Higher Education. The combined $4 million ... years and enables Oklahoma EPSCoR to support research under ... Cellulosic Bioenergy." , Specifically, the funding supports a ...
... in order to survive? The answer changes depending on climate, ... new leaf sprouts. Stanford researchers have found that the ... word stoma, meaning mouth) is controlled by a specific signaling ... stomata development. The findings are described in a paper published ...
Cached Biology News:'Cool' idea for efficient climate control wins recognition 2Oklahoma EPSCoR receives $20 million for biofuels research 2Key link in how plants adapt to climate discovered by Stanford researchers 2
...
... Johnstone and M.W. Turner (1997). • ... methods used in the production of ... in immunoassays, the standardisation of antibodies ... including amplification systems, enzyme immunoassays for ...
... The 1-D PAGE ... Kit for Targeted Protein ... SDS PolyAcrylamide Gel Electrophoresis ... chemistry, and cleavable-linker technology ...
Thermal Printer Paper for Monolight(tm) Luminometer 1 each...
Biology Products: